Blog

  1. Who is winning the market share race?

    In the data we’re releasing today we take a look at which suppliers are gaining the most market share in the primary and secondary research antibody markets, and what their competitors can do to keep up.   As this is the first time CiteAb data has shed light on the companies leading in the secondary […]

  2. Catch up on AbVal16!

    If you follow our blog regularly you couldn’t have missed that last week our team was busy hosting antibody suppliers, academic and industry researchers and professionals from the pharmaceutical and biotech sector here in Bath for the 2nd International Antibody Validation Event. If you weren’t able to join us last week, here is a quick […]

  3. A proposal for the validation of antibodies

    The International Working Group for Antibody Validation, which we have mentioned before here on our blog, has just published its findings. This is especially apt as we embark on a week of antibody validation, with the 2nd International Antibody Validation Event taking place here in Bath on Thursday and Friday. We have had a good […]

  4. The CiteAb team is growing!

    It has been a very busy year for us here at CiteAb – working with more suppliers, seeing huge traffic increases from researchers, and releasing more data reports. For this reason we’ve taken the decision to appoint a full time data scientist – Rhys Williams joins our team this week and he’ll be working on […]

  5. Want to succeed in the Western Blot antibody market?

    Our latest data report focuses on how your company can succeed in the Western Blot antibody market. This builds on our recent blogs which explored techniques for success in IHC and Flow Cytometry, and outlines what suppliers need to offer in order to increase their market share. To produce the data in this report, our […]

Search our blog